Trial intelligence / Profile preview

Remimazolam vs Desflurane Recovery in Nasal Bone Fracture

NCT05774366Unknown

Sponsor
Daegu Catholic University Medical Center
Start
Mar 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Daegu Catholic University Medical Center. Primary endpoint: Time to follow verbal command up to 30 minutes. Status: unknown.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT05774366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05774366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call